How QuickrBio Accelerated Its Platform Development with Labii’s All-in-One Configurable Platform

If you’re building the future of biotech, Labii is here to help you move faster, stay compliant, and scale confidently.

In the fast-paced world of biotechnology, speed and precision are everything—especially for startups racing to bring transformative technologies to market. QuickrBio, a pioneering company focused on accurate and rapid genomics to accelerate the development of cell and gene therapies, exemplifies how the right technological partnership can make or break early-stage momentum. Learn more about QuickrBio.

A Crucial Introduction at the Right Time

In 2024, Charles Blanluet, CEO and Cofounder of QuickrBio, was navigating the early days of forming his company and raising its seed round. At the time, QuickrBio needed to quickly demonstrate the capabilities of its proprietary fluorescent assay kits by building a working analysis platform—without an in-house software team.

Thanks to a timely introduction from Todd Morrill, a shared business advisor, Charles connected with Labii, a company known for its All-in-One Configurable Platform tailored for scientific applications. Labii’s platform provided exactly what QuickrBio needed: a robust foundation for scientific data management and analysis, without requiring any coding knowledge.

Building a Platform with No Code, in No Time

QuickrBio’s product produces complex fluorescent readouts, requiring normalized signal analysis against controls. With Labii, QuickrBio could immediately leverage built-in modules for:

• User management – for credential control and role-based access.

• Electronic Lab Notebook (ELN) – to document assay procedures and outcomes.

• Sample Management – to track biological samples and storage locations.

• LIMS – to manage and document assay workflows end-to-end.

• Secure Cloud Infrastructure – compliant with FDA and HIPAA data security standards.

But the real breakthrough came in co-developing a custom data analysis widget, allowing QuickrBio scientists to upload raw fluorescent data, run control-based normalization, and instantly generate results—directly within their experiment notes.

“Labii is a life saver. It helped us deliver a working demo that secured our seed round,” said Charles Blanluet, CTO of QuickrBio.

Strategic Partnerships Fuel Startup Success

This collaboration exemplifies the power of strategic partnerships for biotech startups. Instead of investing time and capital in building infrastructure from scratch, QuickrBio was able to focus entirely on its scientific innovation and fundraising goals. With Labii’s support, they transformed what could have taken months into a working system in just a few weeks.

A Call to Fellow Innovators

Many early-stage biotech companies struggle to build custom data management systems that fit their evolving workflows. With limited headcount and long development cycles, innovation is often slowed by the tools meant to support it.

Labii offers a smarter path forward. Our platform empowers startups to configure applications tailored to their research—without writing code, with systems ready in weeks, and with flexibility to evolve as needs change.

“Labii enables customers to focus on their work—not on creating tools for their work,” said Yonggan Wu, CEO of Labii.

If you’re building the future of biotech, Labii is here to help you move faster, stay compliant, and scale confidently.

To learn more, schedule a meeting with Labii representatives (https://call.schedule.labii.com) or create an account (https://www.labii.com/signup/) to try it out yourself.